MiR-371-5p facilitates pancreatic cancer cell proliferation and decreases patient survival

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  He, De ^a   Miao, Huilai ^b   Xu, Yumin ^a   Xiong, Longhui ^a   Wang, Yi ^a   Xiang, Hongxia ^a   Zhang, Heng ^c   Zhang, Zhiyong ^d  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

^c CHINA THREE GORGES UNIVERSITY   (China)

^d ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 371 5P; UNCLASSIFIED DRUG; ING1 PROTEIN, HUMAN; MIRN371 MICRORNA, HUMAN; NUCLEAR PROTEIN; SIGNAL PEPTIDE; TUMOR SUPPRESSOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CARCINOGENESIS; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DISEASE ACTIVITY; DOWN REGULATION; FLOW CYTOMETRY; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREATIC CANCER CELL LINE; PROMOTER REGION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; TUMOR XENOGRAFT; WESTERN BLOTTING; ANIMAL; CANCER TRANSPLANTATION; GENE EXPRESSION REGULATION; GENETICS; MORTALITY; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; SURVIVAL; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICRORNAS; NEOPLASM TRANSPLANTATION; NUCLEAR PROTEINS; PANCREATIC NEOPLASMS; PROMOTER REGIONS, GENETIC; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 84912139953     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112930     Document Type: Article

References (21)

1. Keane MG, Bramis K, Pereira SP, Fusai GK (2014) Systematic review of novel ablative methods in locally advancedpancreatic cancer. World J Gastr-oenterol 20: 2267-2278.
2. Oettle H, Neuhaus P, Hochhaus A, Hartmann JT, Gellert K, et al. (2013) Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial. JAMA 310: 1473-1481.
3. Marin-Muller C, Li D, Bharadwaj U, Li M, Chen C, et al. (2013) A tumorigenic factor interactome connected through tumor suppressor microRNA-198 in human pancreatic cancer. Clin Cancer Res 19: 5901-5913.
4. Iwagami Y, Eguchi H, Nagano H, Akita H, Hama N, et al. (2013) miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1. Br J Cancer 109: 502-511.
5. Mace TA, Collins AL, Wojcik SE, Croce CM, Lesinski GB, et al. (2013) Hypoxia induces the overexpression of microRNA-21 in pancreatic cancer cells. J Surg Res 184: 855-860.
6. Sicard F, Gayral M, Lulka H, Buscail L, Cordelier P (2013) Targeting miR-21 for the therapy of pancreatic cancer. Mol Ther 21: 986-994.
7. Kawaguchi T, Komatsu S, Ichikawa D, Morimura R, Tsujiura M, et al. (2013) Clinical impact of circulating miR-221 in plasma of patients withpancreatic cancer. Br J Cancer 108: 361-369.
8. Hamada S, Satoh K, Miura S, Hirota M, Kanno A, et al. (2013) miR-197 induces epithelial-mesenchymal transition in pancreatic cancer cells by targeting p120 catenin. J Cell Physiol 228: 1255-1263.
9. Liu H, Zhu L, Liu B, Yang L, Meng X, et al. (2012) Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. Cancer Lett 316: 196-203.
10. Liu RY, Diao CF, Zhang Y, Wu N, Wan HY, et al. (2013) miR-371-5p downregulates pre mRNA processing factor 4 homolog B (PRPF4B) and facilitates the G1/S transition in human hepatocellular carcinoma cells. Cancer Lett 335: 351-360.
11. Chen J, Tran UM, Rajarajacholan U, Thalappilly S, Riabowol K (2013)ING1binducible microRNA203 inhibits cell proliferation. Br J Cancer 108: 1143-1148.
12. Guo XB, Jing CQ, Li LP, Zhang L, Shi YL, et al. (2011) Down-regulation of miR-622 in gastric cancer promotes cellular invasion and tumor metastasis by targeting ING1 gene. World J Gastroenterol 17: 1895-1902.
13. Ali S, Saleh H, Sethi S, Sarkar FH, Philip PA. (2012) MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancer. Br J Cancer 107: 1354-1360.
14. Vimalraj S, Selvamurugan N (2014) MicroRNAs expression and their regulatory networks during mesenchymal stem cells differentiation toward osteoblasts. Int J Biol Macromol 66: 194-202.
15. Wang WL, Chatterjee N, Chittur SV, Welsh J, Tenniswood MP (2011) Effects of 1a, 25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol Cancer 10: 58-65.
16. Guérillon C, Bigot N, Pedeux R (2014) The ING tumor suppressor genes: Status in human tumors. Cancer Lett 345: 1-16.
17. Guérillon C, Larrieu D, Pedeux R (2013) ING1 and ING2: multifaceted tumor suppressor genes. Cell Mol Life Sci 70: 3753-3772.
18. Coles AH, Liang H, Zhu Z, Marfella CG, Kang J, et al. (2007) Deletion of p37Ing1 in mice reveals a p53-independent role for Ing1 in the suppression of cell proliferation, apoptosis, and tumorigenesis. Cancer Res 67: 2054-2061.
19. Champagne KS, Kutateladze TG (2009) Structural insight into histone recognition by the ING PHD fingers. Curr Drug Targets 10: 432-441.
20. Larson RA (2010) Micro-RNAs and copy number changes: new levels of gene regulation in acute myeloid leukemia. Chem Biol Interact 184: 21-25.
21. Ingelman-Sundberg M, Zhong XB, Hankinson O, Beedanagari S, Yu AM, et al. (2013) Potential role of epigenetic mechanisms in the regulation of drug metabolism and transport. Drug Metab Dispos 41: 1725-31.